Chathuri Abeyakoon

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Innovative approaches for managing relapsed or refractory peripheral T-cell lymphoma.

Innovative approaches for managing relapsed or refractory peripheral T-cell lymphoma.

Journal: Expert opinion on pharmacotherapy

Published: April 28, 2026

Relapsed classic Hodgkin lymphoma; should all patients receive an autologous stem cell transplant? - the PRO.

Relapsed classic Hodgkin lymphoma; should all patients receive an autologous stem cell transplant? - the PRO.

Journal: Haematologica

Published: January 21, 2026

End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.

End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.

Journal: British journal of haematology

Published: December 29, 2025

Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma.

Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma.

Journal: Blood

Published: September 02, 2025

Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell Lymphoma.

Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell Lymphoma.

Journal: International journal of molecular sciences

Published: June 07, 2025

Inferior survival in double refractory large B-cell lymphoma eligible for third-line CD19 CAR T-cell therapy.

Inferior survival in double refractory large B-cell lymphoma eligible for third-line CD19 CAR T-cell therapy.

Journal: Blood neoplasia

Published: May 09, 2025

Clinical characteristics and disease outcomes of primary bone lymphoma in the rituximab era: a retrospective study from the Princess Margaret Cancer Center, Toronto, Canada.

Clinical characteristics and disease outcomes of primary bone lymphoma in the rituximab era: a retrospective study from the Princess Margaret Cancer Center, Toronto, Canada.

Journal: Leukemia & lymphoma

Published: February 22, 2025

Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges.

Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges.

Journal: Expert review of hematology

Published: June 25, 2024

New standards of care for treatment of diffuse large B-cell lymphoma.

New standards of care for treatment of diffuse large B-cell lymphoma.

Journal: British journal of haematology

Published: December 26, 2023

Definitions of massive transfusion in adults with critical bleeding: a systematic review.

Definitions of massive transfusion in adults with critical bleeding: a systematic review.

Journal: Critical care (London, England)

Published: May 31, 2023

Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance.

Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance.

Journal: Haematologica

Published: May 09, 2022

Targeted Approaches to T-Cell Lymphoma.

Targeted Approaches to T-Cell Lymphoma.

Journal: Journal of personalized medicine

Published: May 12, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026